{
  "question": "Metoclopramide has the following actions EXCEPT:",
  "is_multi_choice": true,
  "correct_answer": "opd",
  "options": {
    "opa": "Increase lower esophageal sphincter tone",
    "opb": "Prokinetic action is blocked by atropine",
    "opc": "Increase gastric peristalsis",
    "opd": "Increase large intestinal peristalsis"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Metoclopramide",
        "Disease",
        "Obstruction"
      ],
      [
        "Metoclopramide",
        "Obesity",
        "Obstruction"
      ],
      [
        "Metoclopramide",
        "Epilepsy",
        "Obstruction"
      ]
    ],
    "relationships": [
      [
        "TREATS",
        "CAUSES"
      ],
      [
        "TREATS",
        "CAUSES"
      ],
      [
        "TREATS",
        "CAUSES"
      ]
    ],
    "paths": [
      "(Metoclopramide)-TREATS->(Disease)-CAUSES->(Obstruction)",
      "(Metoclopramide)-TREATS->(Obesity)-CAUSES->(Obstruction)",
      "(Metoclopramide)-TREATS->(Epilepsy)-CAUSES->(Obstruction)"
    ]
  },
  "causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Metoclopramide",
        "Disease",
        "Physiologic Function",
        "Inferior esophageal sphincter structure"
      ],
      [
        "Metoclopramide",
        "Obesity",
        "physiological aspects",
        "Inferior esophageal sphincter structure"
      ],
      [
        "Metoclopramide",
        "Obesity",
        "Muscle Contraction",
        "Inferior esophageal sphincter structure"
      ],
      [
        "Metoclopramide",
        "Disease",
        "Excretory function",
        "Intestines, Small"
      ],
      [
        "Metoclopramide",
        "Disease",
        "Neutrophil Infiltration",
        "Intestines, Small"
      ],
      [
        "Metoclopramide",
        "Disease",
        "uptake",
        "Intestines, Small"
      ]
    ],
    "relationships": [
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "PROCESS_OF"
      ]
    ],
    "paths": [
      "(Metoclopramide)-TREATS->(Disease)-MANIFESTATION_OF->(Physiologic Function)-PROCESS_OF->(Inferior esophageal sphincter structure)",
      "(Metoclopramide)-TREATS->(Obesity)-MANIFESTATION_OF->(physiological aspects)-PROCESS_OF->(Inferior esophageal sphincter structure)",
      "(Metoclopramide)-TREATS->(Obesity)-MANIFESTATION_OF->(Muscle Contraction)-PROCESS_OF->(Inferior esophageal sphincter structure)",
      "(Metoclopramide)-TREATS->(Disease)-MANIFESTATION_OF->(Excretory function)-PROCESS_OF->(Intestines, Small)",
      "(Metoclopramide)-TREATS->(Disease)-MANIFESTATION_OF->(Neutrophil Infiltration)-PROCESS_OF->(Intestines, Small)",
      "(Metoclopramide)-TREATS->(Disease)-MANIFESTATION_OF->(uptake)-PROCESS_OF->(Intestines, Small)"
    ]
  },
  "knowledge_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Inferior esophageal sphincter structure",
        "Gastroesophageal reflux disease"
      ],
      [
        "Atropine",
        "agonists",
        "Anticholinergic Agents"
      ],
      [
        "Atropine",
        "Mydriatics",
        "Anticholinergic Agents"
      ],
      [
        "Atropine",
        "Pharmaceutical Preparations",
        "Anticholinergic Agents"
      ],
      [
        "Intestines, Small",
        "Intestines"
      ]
    ],
    "relationships": [
      [
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "ISA"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "PART_OF"
      ]
    ],
    "paths": [
      "(Inferior esophageal sphincter structure)-LOCATION_OF->(Gastroesophageal reflux disease)",
      "(Atropine)-INTERACTS_WITH->(agonists)-INTERACTS_WITH->(Anticholinergic Agents)",
      "(Atropine)-INTERACTS_WITH->(Mydriatics)-ISA->(Anticholinergic Agents)",
      "(Atropine)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Anticholinergic Agents)",
      "(Intestines, Small)-PART_OF->(Intestines)"
    ]
  },
  "enhanced_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": [
      "(Metoclopramide)-TREATS->(Disease and Obesity)-MANIFESTATION_OF->(Muscle Contraction and Physiologic Function and physiological aspects)-PROCESS_OF->(Inferior esophageal sphincter structure)",
      "(Metoclopramide)-TREATS->(Disease)-MANIFESTATION_OF->(Excretory function and Neutrophil Infiltration and uptake)-PROCESS_OF->(Intestines, Small)",
      "(Inferior esophageal sphincter structure)-LOCATION_OF->(Gastroesophageal reflux disease)",
      "(Atropine)-INTERACTS_WITH->(agonists)-INTERACTS_WITH->(Anticholinergic Agents)",
      "(Atropine)-INTERACTS_WITH->(Mydriatics)-ISA->(Anticholinergic Agents)",
      "(Atropine)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Anticholinergic Agents)",
      "(Intestines, Small)-PART_OF->(Intestines)"
    ]
  },
  "reasoning_chain": [
    "Metoclopramide is a prokinetic agent -> It increases lower esophageal sphincter tone -> This action helps prevent gastroesophageal reflux -> 90%",
    "Metoclopramide enhances gastric motility -> It increases gastric peristalsis -> This action aids in gastric emptying -> 85%",
    "Metoclopramide's prokinetic action is not affected by atropine -> Atropine is an anticholinergic agent -> It typically inhibits gastrointestinal motility -> 80%",
    "Metoclopramide does not significantly increase large intestinal peristalsis -> Its primary effects are on the stomach and small intestine -> This suggests limited action on the large intestine -> 75%"
  ],
  "enhanced_information": "Metoclopramide is a prokinetic agent that primarily increases lower esophageal sphincter tone and gastric peristalsis, aiding in gastric emptying. However, its prokinetic action is not significantly affected by atropine, which is an anticholinergic agent that typically inhibits gastrointestinal motility. Importantly, metoclopramide does not significantly increase large intestinal peristalsis, as its primary effects are on the stomach and small intestine. Therefore, the correct answer to the question is that metoclopramide does not increase large intestinal peristalsis.",
  "analysis": "Metoclopramide is known for its prokinetic properties, which include increasing lower esophageal sphincter tone and enhancing gastric peristalsis. It is effective in promoting gastric emptying and is often used in conditions like gastroparesis. The statement that its prokinetic action is blocked by atropine is misleading; while atropine does inhibit gastrointestinal motility, metoclopramide's action is primarily mediated through dopamine receptor antagonism and is not significantly affected by anticholinergic agents like atropine. Furthermore, metoclopramide does not significantly increase large intestinal peristalsis, as its primary effects are on the upper gastrointestinal tract. Therefore, the correct answer is that metoclopramide does not increase large intestinal peristalsis, making option opd the correct choice.",
  "answer": "opd",
  "confidence": 90.0,
  "chain_coverage": {
    "success_counts": [
      0,
      0,
      1,
      2
    ],
    "coverage_rates": [
      0.0,
      0.0,
      33.33333333333333,
      66.66666666666666
    ],
    "total_successes": 3
  }
}